Showing results (91-100 of 132) with videos related to

Sort By:
Pageof 14
The Journal of Biological Chemistry|February 2, 2011
Energy restriction-mimetic agents induce apoptosis in prostate cancer cells in part through epigenetic activation of KLF6 tumor suppressor gene expressionChun-Han Chen, Po-Hsien Huang, Po-Chen Chu, et al.
Neoplasia (New York, N.Y.)|July 9, 2015
Function of Integrin-Linked Kinase in Modulating the Stemness of IL-6-Abundant Breast Cancer Cells by Regulating γ-Secretase-Mediated Notch1 Activation in CaveolaeEn-Chi Hsu, Samuel K Kulp, Han-Li Huang, et al.
Pharmaceutical Research|June 29, 2011
Liposomes containing (-)-gossypol-enriched cottonseed oil suppress Bcl-2 and Bcl-xL expression in breast cancer cellsHong Li, Longzhu Piao, Pingping Xu, et al.
Molecular Pharmacology|August 4, 2007
2-amino-N-{4-[5-(2-phenanthrenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]-phenyl} acetamide (OSU-03012), a celecoxib derivative, directly targets p21-activated kinaseLeonardo M Porchia, Marcy Guerra, Yu-Chieh Wang, et al.
Cancer Research|February 19, 2008
FTY720 induces apoptosis in hepatocellular carcinoma cells through activation of protein kinase C delta signalingJui-Hsiang Hung, Yen-Shen Lu, Yu-Chieh Wang, et al.
Cancer Research|June 5, 2007
Histone deacetylase inhibitors sensitize prostate cancer cells to agents that produce DNA double-strand breaks by targeting Ku70 acetylationChang-Shi Chen, Yu-Chieh Wang, Hsiao-Ching Yang, et al.
Cancer Research|August 19, 2007
A potent indole-3-carbinol derived antitumor agent with pleiotropic effects on multiple signaling pathways in prostate cancer cellsJing-Ru Weng, Chen-Hsun Tsai, Samuel K Kulp, et al.
Science Signaling|March 21, 2013
Vitamin E facilitates the inactivation of the kinase Akt by the phosphatase PHLPP1Po-Hsien Huang, Hsiao-Ching Chuang, Chih-Chien Chou, et al.
Hepatology (Baltimore, Md.)|July 27, 2007
Efficacy of a novel histone deacetylase inhibitor in murine models of hepatocellular carcinomaYen-Shen Lu, Yoko Kashida, Samuel K Kulp, et al.
Carcinogenesis|June 1, 2014
Targeting the Warburg effect with a novel glucose transporter inhibitor to overcome gemcitabine resistance in pancreatic cancer cellsI-Lu Lai, Chih-Chien Chou, Po-Ting Lai, et al.
Pageof 14